Evidence map›Paper›PMID 41631048›Full record

ArticleCureus2026

Paraneoplastic Encephalitis Unmasking Small-Cell Lung Cancer With Impending Superior Vena Cava Obstruction: A Case Report.

Halima Zaman, Raksaini Sivasubramaniam, Zainab Akbar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Halima ZamanOncology, Royal Preston Hospital, Preston, GBR.
Raksaini SivasubramaniamOncology, Royal Preston Hospital, Preston, GBR.
Zainab AkbarEmergency, Royal Preston Hospital, Preston, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small-cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma that accounts for approximately 15% of all lung cancers and is strongly associated with paraneoplastic syndromes. Among these, paraneoplastic encephalitis (PE) is a rare, immune-mediated inflammation that leads to neuropsychiatric symptoms, seizures, and memory impairment. It may precede the diagnosis of malignancy by weeks to months. Superior vena cava obstruction (SVCO), in contrast, is a more common oncological emergency. Their concurrent presentation as the initial manifestations of SCLC is an uncommon occurrence. We report the case of a 57-year-old woman with a strong history of smoking, who presented with acute behavioral changes and seizures. Despite negative onconeural antibody testing, her presentation was strongly suggestive of autoimmune encephalitis. Immunotherapy with corticosteroids, plasma exchange, and intravenous immunoglobulin was trialed, but her neurological symptoms persisted. Subsequently, she developed neck swelling and dyspnea - imaging revealed mediastinal lymphadenopathy with venous compression concerning for impending SVCO. Endobronchial ultrasound-guided biopsy confirmed small-cell lung carcinoma. She was commenced on carboplatin-etoposide chemotherapy, which led to a clinical improvement in both neurological and obstructive symptoms. This case highlights the diagnostic complexity of paraneoplastic encephalitis, which can mimic psychiatric or infectious causes. Awareness of this rare presentation is crucial, as timely identification and prompt oncological intervention can significantly improve outcomes in patients presenting with unexplained neuropsychiatric symptoms or new-onset seizures.

Indexed as

autoantibodiesautoimmune encephalitisfirst episode psychosisnew-onset seizureparaneoplastic encephalitis syndromessmall-cell lung carcinomasuperior vena cava (svc) obstruction

Identifiers

PMID41631048
PMCPMC12861485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.